Regional Monitoring EECA
by ECUO PLWH
Showing 1-83 of 83 items.
Excel
#CountrySource of financingManufacturerTradenameINNFormPrice per unit ($)Units in purchaseUnits in packagePrice per package ($)Packages in purchasePrice per purchase ($)DistributorYearPurchase dateDelivery dateRegisteredIn the list of main (vital) medicationsWHO prequalification
1Republic of LithuaniaInsurance FundAbbVieKaletraLopinavir+Ritonavir - FDC100mg+25mg tab3.5633120120427.61427.62016YesYesNot specified
2Republic of EstoniaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC200mg+50mg tab3.6984120120443.811443.812015Not specifiedNot specifiedNot specified
3GeorgiaGlobal FundAbbVieAluviaLopinavir+Ritonavir - FDC100mg+25mg tab0.50671896012060.81589606.4partnership for supply. chain management (PFSCM)2016YesYesNot specified
4Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC100mg+25mg tab3.0222291600120362.662430881263.81Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
5Republic of LatviaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC200mg+50mg tab2.9628120120355.541355.542015Not specifiedNot specifiedNot specified
6Republic of LatviaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC200mg+50mg tab3.3617237600120403.41980798732National Health Service (NHC)2016Not specifiedNot specifiedNot specified
7Republic of UzbekistanGlobal FundAurobindo Pharma Ltd.Lopinavir+Ritonavir - FDC200mg+50mg tab0.02811201203.3713.372015Not specifiedNot specifiedNot specified
8Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC200mg+50mg tab3.4264180000120411.1715006167552015Not specifiedNot specifiedNot specified
9Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC200mg+50mg tab3.42921260000120411.51050043207502015Not specifiedNot specifiedNot specified
10Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC100mg+25mg tab3.118224000120374.1820074836Krajowe Centrum ds. AIDS2016Not specifiedYesNot specified
11UkraineGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.506712012060.8160.82015Not specifiedNot specifiedNot specified
12UkraineGovernmentAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.54181303212012065.0210860170612372016Not specifiedNot specifiedNot specified
13Republic of BelarusGlobal FundAbbVieAluviaLopinavir+Ritonavir - FDC200mg+50mg tab0.5007209652012060.08174711049657.62UNDP/UNICEF2016YesYesNot specified
14Republic of MoldovaGovernmentAbbVieAluviaLopinavir+Ritonavir - FDC200mg+50mg tab0.577134200012069.252850197362.5Dita Estfarm SRL2015Not specifiedNot specifiedNot specified
15Republic of MoldovaGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.506717004012060.8141786153.62015Not specifiedNot specifiedNot specified
16GeorgiaGlobal FundAbbVieAluviaLopinavir+Ritonavir - FDC200mg+50mg tab0.506757024012060.84752288921.59partnership for supply. chain management (PFSCM)2016YesYesNot specified
17Republic of ArmeniaGlobal FundAbbVieAluviaLopinavir+Ritonavir - FDC200mg+50mg tab0.506714472012060.8120673324.8partnership for supply. chain management (PFSCM)2016YesYesNot specified
18Republic of ArmeniaGlobal FundAbbVieAluviaLopinavir+Ritonavir - FDC200mg+50mg tab0.506711160012060.893056544partnership for supply. chain management (PFSCM)2016YesYesNot specified
19Republiс of AzerbaijanGovernmentAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab1.2519495360120150.234128620149.442015YesYesNot specified
20Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC100mg+25mg tab3.1157744000120373.8862002318056Krajowe Centrum ds. AIDS2016YesYesNot specified
21Republic of TajikistanGlobal FundAurobindo Pharma Ltd.Lopinavir+Ritonavir - FDC200mg+50mg tab0.166747232012020393678720UNDP/UNICEFNot specifiedNot specifiedNot specified
22Republic of BelarusGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.50674980012060.841525232UNICEF Supply Division20152015-12-222016-03-01Not specifiedNot specifiedNot specified
23Republic of MoldovaGlobal FundAbbVieAluviaLopinavir+Ritonavir - FDC200mg+50mg tab0.506734020012060.82835172368IDA FoundationNot specifiedNot specifiedNot specified
24Republic of MoldovaGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.506717016012060.8141886214.4IDA Foundation2015Not specifiedYesNot specified
25UkraineGlobal FundAbbVieAluviaLopinavir+Ritonavir - FDC200mg+50mg tab0.5067700308012060.8583593548227.252016YesYesNot specified
26Republic of ArmeniaGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.50678460012060.870542864VPP, through Partnership for Supply Chain Management (PFSCM)20152015-05-112015-10-14Not specifiedNot specifiedNot specified
27GeorgiaGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.506745144012060.83762228729.59partnership for supply. chain management (PFSCM)2015YesNot specifiedNot specified
28UkrainePEPFARAbbVieAluviaLopinavir+Ritonavir - FDC200mg+50mg tab0.5067421548012060.8351292135843.252016YesYesNot specified
29Republic of BelarusGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.506712000012060.8100060800UNICEF Supply Division20152015-11-042016-01-30Not specifiedNot specifiedNot specified
30Republic of BelarusGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.506718000012060.8150091200UNICEF Supply Division20152015-11-192016-02-17Not specifiedNot specifiedNot specified
31Republic of BelarusGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.506784816012060.87068429734.41UNICEF Supply Division20152015-11-252016-03-01Not specifiedNot specifiedNot specified
32Russian FederationGovernmentAbbottKaletraLopinavir+Ritonavir - FDC200mg+50mg tab1.050882860720120126.1690506870728082015Not specifiedNot specifiedNot specified
33Republic of LithuaniaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC200mg+50mg tab3.3937120120407.251407.252015Not specifiedYesNot specified
34Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC200mg+50mg tab3.4291240000120411.4920008229802015Not specifiedNot specifiedNot specified
35Kyrgyz RepublicGlobal FundCipla LtdLopinavir+Ritonavir - FDC200mg+50mg tab0.2083-12025--UNDP/UNICEF2015Not specifiedNot specifiedNot specified
36Russian FederationGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC200mg+50mg tab0.9110272360120109.28560393478482016YesYesNot specified
37Republic of TajikistanGlobal FundAurobindo Pharma Ltd.Lopinavir+Ritonavir - FDC200mg+50mg tab0.506712012060.8160.82015Not specifiedNot specifiedNot specified
38Republic of UzbekistanGlobal FundAurobindo Pharma Ltd.Lopinavir+RitonavirLopinavir+Ritonavir - FDC200mg+50mg tab0.02811201203.3713.372016YesYesYes
39Republic of LithuaniaInsurance FundAbbVieKaletraLopinavir+Ritonavir - FDC200mg+50mg tab1.78176060106.91106.92016YesYesNot specified
40Republic of LatviaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC100mg+25mg tab2.029396060121.74668034.84National Health Service (NHC)2016Not specifiedNot specifiedNot specified
41UkrainePEPFARAbbVieAluviaLopinavir+Ritonavir - FDC100mg+25mg tab0.25351747806015.21291344306.732016YesYesNot specified
42Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC200mg+50mg tab3.66551020060219.9317037388.1Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
43Republic of MoldovaGovernmentAbbVieAluviaLopinavir+Ritonavir - FDC100mg+25mg tab0.3127739206018.76123223112.32Dita Estfarm SRLNot specifiedNot specifiedNot specified
44Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC100mg+25mg tab3.1157420060186.947013085.8Krajowe Centrum ds. AIDS2016YesYesNot specified
45UkraineGovernmentAbbVieAluviaLopinavir+Ritonavir - FDC100mg+25mg tab0.2713015206016.221692351410.41YesNot specifiedNot specified
46Russian FederationGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC100mg+25mg tab1.537505206092.2284277649.242016YesYesNot specified
47Republic of MoldovaGlobal FundAbbVieAluviaLopinavir+Ritonavir - FDC100mg+25mg tab0.3497283206020.984729902.56IDA FoundationNot specifiedNot specifiedNot specified
48Republic of TajikistanGlobal FundAurobindo Pharma Ltd.Lopinavir+Ritonavir - FDC100mg+25mg tab0.128377760607.712969979.2UNDP/UNICEFNot specifiedNot specifiedNot specified
49Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC100mg+25mg tab3.42921500060205.7525051437.52015Not specifiedNot specifiedNot specified
50Republic of TajikistanGlobal FundAbbVieLopinavir+Ritonavir - FDC100mg+25mg tab0.128360607.717.72015Not specifiedNot specifiedNot specified
51UkraineGovernmentAbbVieLopinavir+Ritonavir - FDC100mg+25mg tab0.270813014606016.2521691352478.752015Not specifiedNot specifiedNot specified
52Republic of LatviaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC100mg+25mg tab1.71376060102.821102.822015Not specifiedNot specifiedNot specified
53Russian FederationGovernmentAbbottKaletraLopinavir+Ritonavir - FDC100mg+25mg tab1.724894344060103.49157241627276.752015Not specifiedNot specifiedNot specified
54Republic of MoldovaGlobal FundAbbVieLopinavir+Ritonavir - FDC100mg+25mg tab0.3497144006020.982405035.22015Not specifiedNot specifiedNot specified
55Republic of MoldovaGlobal FundAbbVieLopinavir+Ritonavir - FDC100mg+25mg tab0.3497139206020.982324867.362015Not specifiedNot specifiedNot specified
56Republic of KazakhstanGovernmentAbbVieLopinavir+Ritonavir - FDC100mg+25mg tab0.007885190400600.471419840667324.812015Not specifiedNot specifiedNot specified
57Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC100mg+25mg tab3.4292480060205.7580164602015Not specifiedNot specifiedNot specified
58Republic of KazakhstanGovernmentAbbVieLopinavir+Ritonavir - FDC100mg+25mg tab0.00224428000600.137380095942015Not specifiedNot specifiedNot specified
59Republic of LithuaniaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC100mg+25mg tab1.69686060101.811101.812015Not specifiedYesNot specified
60Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml61.7982505308.995015449.52015Not specifiedNot specifiedNot specified
61Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml61.8375530975231752015Not specifiedNot specifiedNot specified
62Republic of LithuaniaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml74.576-5372.88--2015Not specifiedYesNot specified
63Republic of MoldovaGlobal FundAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml2.4321125512.162252736IDA FoundationNot specifiedNot specifiedNot specified
64Kyrgyz RepublicGlobal FundAbbVieKaletraLopinavir+Ritonavir - FDC80mg/ml+20mg/ml oral solution 100ml12.16-560.8--UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
65Republic of KazakhstanGovernmentAesica Queenborough Limited, Great BritainLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml2.37211175511.86223526507.12015Not specifiedNot specifiedNot specified
66GeorgiaGlobal FundAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml12.16255560.8513100.8partnership for supply. chain management (PFSCM)2015NoYesNot specified
67Republic of UzbekistanGlobal FundAesica Queenborough LimitedKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml12.165560.8160.82016NoYesYes
68Republic of TajikistanGlobal FundAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml12.16-560.8--2015Not specifiedNot specifiedNot specified
69GeorgiaGlobal FundAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml12.1640560.88486.4partnership for supply. chain management (PFSCM)2016YesYesNot specified
70Republiс of AzerbaijanGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml42.09821005210.4942088405.82015YesYesNot specified
71UkraineGovernmentAbbVieLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml0.236100717051.18201434237692.122015Not specifiedNot specifiedNot specified
72Republic of EstoniaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml88.762-5443.81--2015Not specifiedNot specifiedNot specified
73Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg/ml+20mg/ml oral solution 100ml59.1041505295.52308865.6Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
74Republic of LatviaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml81.46855407.341407.342015Not specifiedNot specifiedNot specified
75Republic of LatviaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml92.2281555461.143114295.34National Health Service (NHC)2016Not specifiedNot specifiedNot specified
76Republic of UzbekistanGlobal FundAesica Queenborough Limited, Great BritainLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml12.16-560.8--2015Not specifiedNot specifiedNot specified
77Republic of BelarusGlobal FundAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml60.8105160.81056384UNDP/UNICEF2016YesYesNot specified
78Republic of MoldovaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml13.85510113.855107063.5Dita Estfarm SRL2015Not specifiedNot specifiedNot specified
79Republic of TajikistanGlobal FundAurobindo Pharma Ltd.Lopinavir+Ritonavir - FDC80mg/ml+20mg/ml oral solution 100ml12.2504112.25046148.8UNDP/UNICEFNot specifiedNot specifiedNot specified
80UkraineGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml64.773357164.773357217432.892016YesYesNot specified
81Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg/ml+20mg/ml oral solution 100ml295.52201295.52205910.4Krajowe Centrum ds. AIDS2016YesYesNot specified
82Russian FederationGovernmentAesica Queenborough LimitedKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml21.451050121.45105022522.52016YesYesYes
83Republic of LithuaniaInsurance FundAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml391.5211391.521391.522016YesYesNot specified